E-LIB Suche - Ergebnisse für: VANĚČKOVÁ, Ivana

1

More efficient adaptation of cardiovascular response to rep..:

Vavřínová, Anna ; Behuliak, Michal ; Vodička, Martin...
Hypertension Research. , 2024

Link: https://doi.org/10.1038/..

2

Changes in cardiovascular autonomic control induced by chro..:

Bencze, Michal ; Boroš, Almos ; Behuliak, Michal...
European Journal of Pharmacology. 971 (2024) - p. 176526 , 2024

Link: https://doi.org/10.1016/..

3

Chronic inhibition of angiotensin converting enzyme lowers ..:

Behuliak, Michal ; Bencze, Michal ; Boroš, Almos...
Biomedicine & Pharmacotherapy. 176 (2024) - p. 116796 , 2024

Link: https://doi.org/10.1016/..

4

Hepatoprotective and cardioprotective effects of empagliflo..:

Hojná, Silvie ; Malínská, Hana ; Hüttl, Martina...
Biomedicine & Pharmacotherapy. 174 (2024) - p. 116520 , 2024

Link: https://doi.org/10.1016/..

5

Endothelin type A receptor blockade increases renoprotectio..:

Kala, Petr ; Vaňourková, Zdenka ; Škaroupková, Petra...
Biomedicine & Pharmacotherapy. 158 (2023) - p. 114157 , 2023

Link: https://doi.org/10.1016/..

6

Impaired vascular β-adrenergic relaxation in spontaneously ..:

Valovič, Pavol ; Behuliak, Michal ; Vaněčková, Ivana.
European Journal of Pharmacology. 958 (2023) - p. 176045 , 2023

Link: https://doi.org/10.1016/..

7

Endothelin type A receptor blockade attenuates aorto-caval ..:

Kala, Petr ; Gawrys, Olga ; Miklovič, Matúš...
Journal of Hypertension. 41 (2022) 1 - p. 99-114 , 2022

Link: https://doi.org/10.1097/..

8

Effects of acetylcholinesterase inhibition with pyridostigm..:

Bencze, Michal ; Boroš, Almos ; Vavřínová, Anna...
Journal of Molecular and Cellular Cardiology. 173 (2022) - p. S125 , 2022

Link: https://doi.org/10.1016/..

9

Beneficial Effects of Empagliflozin Are Mediated by Reduced..:

Malínská, Hana ; Hüttl, Martina ; Marková, Irena...
Biomedicines. 10 (2022) 9 - p. 2066 , 2022

Link: https://doi.org/10.3390/..

10

Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Mod..:

Hojná, Silvie ; Kotsaridou, Zoe ; Vaňourková, Zdeňka...
Biomedicines. 10 (2022) 10 - p. 2509 , 2022

Link: https://doi.org/10.3390/..

11

Antihypertensive and metabolic effects of empagliflozin in ..:

Hojná, Silvie ; Rauchová, Hana ; Malínská, Hana...
Biomedicine & Pharmacotherapy. 144 (2021) - p. 112246 , 2021

Link: https://doi.org/10.1016/..

12

In a Prediabetic Model, Empagliflozin Improves Hepatic Lipi..:

Hüttl, Martina ; Markova, Irena ; Miklankova, Denisa...
International Journal of Molecular Sciences. 22 (2021) 21 - p. 11513 , 2021

Link: https://doi.org/10.3390/..

13

Effects of systemic and renal intramedullary endothelin-1 r..:

Bądzyńska, Bożena ; Vaneckova, Ivana ; Sadowski, Janusz..
European Journal of Pharmacology. 910 (2021) - p. 174445 , 2021

Link: https://doi.org/10.1016/..

14

Cooperation of augmented calcium sensitization and increase..:

Zicha, Josef ; Behuliak, Michal ; Vavřínová, Anna...
Hypertension Research. 44 (2021) 9 - p. 1067-1078 , 2021

Link: https://doi.org/10.1038/..

15

Both central sympathoexcitation and peripheral angiotensin ..:

Řezáčová, Lenka ; Vaněčková, Ivana ; Hojná, Silvie...
Hypertension Research. 45 (2021) 3 - p. 414-423 , 2021

Link: https://doi.org/10.1038/..